a , Dose-response curves showing relative cell number after 72 h of treatment of HCC-1806 cells with vincristine (0-5 nM) in the presence of the MRP1 inhibitor MK-571 (0-15 M) (n = 8 technical replicates from one experiment)
Physician-developed by Dr
injectable doses vary by provider Monitoring: serum copper, ceruloplasmin, wound area measurement, infection surveillance Human plasma GHK-Cu declines with age: approximately 200 ng/mL at age 20, approximately 80 ng/mL by age 60 Risk profile: generally well-tolerated topically
Despite treatment, the woman is unable to verbalize or care for herself, requiring an ongoing feeding tube for nutritional support.
Such studies would also provide more information on its long-term safety and efficacy
Which is better, glutathione tablets or vitamin C capsules